X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 91 filers reported holding X4 PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,272 | -43.8% | 55,296 | 0.0% | 0.00% | – |
| Q2 2023 | $107,274 | +107.9% | 55,296 | -6.8% | 0.00% | – |
| Q1 2023 | $51,599 | +87355.9% | 59,309 | 0.0% | 0.00% | – |
| Q4 2022 | $59 | -99.9% | 59,309 | 0.0% | 0.00% | – |
| Q3 2022 | $101,000 | +71.2% | 59,309 | -3.4% | 0.00% | – |
| Q2 2022 | $59,000 | -44.9% | 61,409 | 0.0% | 0.00% | – |
| Q1 2022 | $107,000 | -29.6% | 61,409 | -7.2% | 0.00% | – |
| Q4 2021 | $152,000 | -60.9% | 66,170 | -10.0% | 0.00% | – |
| Q3 2021 | $389,000 | -52.2% | 73,495 | -41.3% | 0.00% | – |
| Q2 2021 | $814,000 | +100.0% | 125,297 | +164.8% | 0.00% | – |
| Q1 2021 | $407,000 | – | 47,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |